EW logo

Edwards Lifesciences (EW) EBIT

Annual EBIT

$1.62 B
-$170.90 M-9.57%

December 31, 2023

Summary

Performance

1-Year Change

-9.57%

3-Year Change

+73.27%

5-Year Change

+104.18%

15-Year Change

+52.7%

EW EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.82%
EW annual earnings before interest & taxes is higher than 96.82% of companies in Healthcare sector

High & Low

All-time High

$1.79 B
EW annual earnings before interest & taxes is currently -9.57% below its historical high of $1.79 billion

3-Year Low

$1.62 B
EW annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EW previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 25, 2025
EW next annual earnings announcement is scheduled for Apr 25, 2025

OtherEWprofitabilitymetrics:

Annual Revenue

$6.00 B
EW annual revenue is $6.00 billion

Annual Net Income

$1.40 B
EW annual net profit is $1.40 billion

Annual EBITDA

$1.76 B
EW annual EBITDA is $1.76 billion

Annual EPS

$2.30
EW annual earnings per share is $2.30

Quarterly EBIT

$394.30 M
+$17.10 M+4.53%

September 30, 2024

Summary

Performance

3-Month Change

+4.53%

1-Year Change

-6.25%

3-Year Change

-0.45%

5-Year Change

+31.48%

EW Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.06%
EW quarterly earnings before interest & taxes is higher than 96.06% of companies in Healthcare sector

High & Low

All-time High

$818.90 M
EW quarterly earnings before interest & taxes is currently -51.85% below its historical high of $818.90 million

3-Year Low

$314.30 M
EW quarterly earnings before interest & taxes is currently +25.45% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
EW next earnings announcement is scheduled for Apr 25, 2025

OtherEWprofitabilitymetrics:

Quarterly Revenue

$1.35 B
EW quarterly revenue is $1.35 billion

Quarterly Net Income

$3.07 B
EW quarterly net profit is $3.07 billion

Quarterly EBITDA

$394.30 M
EW quarterly EBITDA is $394.30 million

Quarterly EPS

$5.13
EW quarterly earnings per share is $5.13

TTM EBIT

$1.52 B
-$26.30 M-1.70%

September 30, 2024

Summary

Performance

3-Month Change

-1.7%

1-Year Change

-9.44%

3-Year Change

+26.91%

5-Year Change

+28.33%

EW TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.31%
EW TTM earnings before interest & taxes is higher than 96.31% of companies in Healthcare sector

High & Low

All-time High

$1.84 B
EW TTM earnings before interest & taxes is currently -17.16% below its historical high of $1.84 billion

3-Year Low

$1.52 B
EW TTM earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
EW next earnings announcement is scheduled for Apr 25, 2025

OtherEWprofitabilitymetrics:

TTM Revenue

$6.60 B
EW TTM revenue is $6.60 billion

TTM Net Income

$4.16 B
EW TTM net profit is $4.16 billion

TTM EBITDA

$1.64 B
EW TTM EBITDA is $1.64 billion

TTM EPS

$6.93
EW TTM earnings per share is $6.93

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

$1.62 B
EW annual earnings before interest & taxes is $1.62 billion

Annual Revenue

$6.00 B
EW annual revenue is $6.00 billion

Annual Cost Of Goods Sold

$1.38 B
EW annual cost of goods sold is $1.38 billion

Annual Operating Expenses

$2.90 B
EW annual total operating expenses is $2.90 billion

EW EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.6%-6.3%-9.4%
3 y3 years+73.3%-0.5%+26.9%
5 y5 years+104.2%+31.5%+28.3%

EW EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.6%at low-20.7%+25.4%-17.2%at low
5 y5-year-9.6%+73.3%-20.7%+1821.8%-17.2%+63.4%
alltimeall time-9.6%+6604.1%-51.9%+839.8%-17.2%+6221.6%

Edwards Lifesciences EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
$394.30 M(+4.5%)
$1.52 B(-1.7%)
Jun 2024
-
$377.20 M(-13.8%)
$1.55 B(-0.5%)
Mar 2024
-
$437.70 M(+39.3%)
$1.56 B(+0.3%)
Dec 2023
$1.62 B(-9.6%)
$314.30 M(-25.3%)
$1.55 B(-7.7%)
Sep 2023
-
$420.60 M(+9.4%)
$1.68 B(-2.0%)
Jun 2023
-
$384.50 M(-11.1%)
$1.72 B(-3.4%)
Mar 2023
-
$432.60 M(-2.7%)
$1.78 B(-0.6%)
Dec 2022
$1.79 B(+3.8%)
$444.60 M(-2.1%)
$1.79 B(-2.8%)
Sep 2022
-
$454.30 M(+2.2%)
$1.84 B(+3.3%)
Jun 2022
-
$444.70 M(+0.4%)
$1.78 B(+0.2%)
Mar 2022
-
$443.00 M(-10.9%)
$1.78 B(+3.3%)
Dec 2021
$1.72 B(+84.5%)
$497.00 M(+25.5%)
$1.72 B(+43.3%)
Sep 2021
-
$396.10 M(-10.4%)
$1.20 B(+3.3%)
Jun 2021
-
$441.90 M(+14.7%)
$1.16 B(+22.3%)
Mar 2021
-
$385.40 M(-1783.0%)
$949.50 M(+1.8%)
Dec 2020
$932.50 M(-21.5%)
-$22.90 M(-106.4%)
$932.50 M(-25.4%)
Sep 2020
-
$357.20 M(+55.4%)
$1.25 B(+4.8%)
Jun 2020
-
$229.80 M(-37.6%)
$1.19 B(-4.2%)
Mar 2020
-
$368.40 M(+24.8%)
$1.25 B(+5.0%)
Dec 2019
$1.19 B(+50.0%)
$295.30 M(-1.5%)
$1.19 B(+31.6%)
Sep 2019
-
$299.90 M(+6.2%)
$902.30 M(+5.8%)
Jun 2019
-
$282.50 M(-8.7%)
$852.80 M(+1.7%)
Mar 2019
-
$309.50 M(+2876.0%)
$838.80 M(+6.0%)
Dec 2018
$791.30 M(-25.2%)
$10.40 M(-95.8%)
$791.30 M(-25.1%)
Sep 2018
-
$250.40 M(-6.7%)
$1.06 B(+2.9%)
Jun 2018
-
$268.50 M(+2.5%)
$1.03 B(+1.7%)
Mar 2018
-
$262.00 M(-5.1%)
$1.01 B(-4.5%)
Dec 2017
$1.06 B(+39.8%)
$276.00 M(+25.1%)
$1.06 B(+10.2%)
Sep 2017
-
$220.70 M(-12.4%)
$960.30 M(+2.7%)
Jun 2017
-
$251.80 M(-18.7%)
$935.00 M(+8.2%)
Mar 2017
-
$309.60 M(+73.7%)
$864.20 M(+14.1%)
Dec 2016
$757.10 M(+18.4%)
$178.20 M(-8.8%)
$757.10 M(+0.9%)
Sep 2016
-
$195.40 M(+8.0%)
$750.50 M(+5.6%)
Jun 2016
-
$181.00 M(-10.6%)
$710.90 M(+5.1%)
Mar 2016
-
$202.50 M(+18.0%)
$676.70 M(+5.8%)
Dec 2015
$639.60 M(-44.9%)
$171.60 M(+10.1%)
$639.60 M(-50.3%)
Sep 2015
-
$155.80 M(+6.1%)
$1.29 B(+2.1%)
Jun 2015
-
$146.80 M(-11.2%)
$1.26 B(+2.2%)
Mar 2015
-
$165.40 M(-79.8%)
$1.23 B(+6.2%)
Dec 2014
$1.16 B(+122.9%)
$818.90 M(+532.4%)
$1.16 B(+124.3%)
Sep 2014
-
$129.50 M(+8.5%)
$517.80 M(+4.9%)
Jun 2014
-
$119.30 M(+27.6%)
$493.80 M(-1.4%)
Mar 2014
-
$93.50 M(-46.7%)
$501.00 M(-3.8%)
Dec 2013
$521.00 M(+32.7%)
$175.50 M(+66.4%)
$521.00 M(+11.8%)
Sep 2013
-
$105.50 M(-16.6%)
$466.00 M(+2.5%)
Jun 2013
-
$126.50 M(+11.5%)
$454.80 M(+8.4%)
Mar 2013
-
$113.50 M(-5.8%)
$419.40 M(+7.0%)
Dec 2012
$392.60 M
$120.50 M(+27.8%)
$392.00 M(+15.0%)
Sep 2012
-
$94.30 M(+3.5%)
$341.00 M(+11.7%)
Jun 2012
-
$91.10 M(+5.8%)
$305.30 M(+6.1%)
DateAnnualQuarterlyTTM
Mar 2012
-
$86.10 M(+23.9%)
$287.70 M(+0.3%)
Dec 2011
$286.70 M(+5.9%)
$69.50 M(+18.6%)
$286.70 M(-0.4%)
Sep 2011
-
$58.60 M(-20.3%)
$287.80 M(-2.8%)
Jun 2011
-
$73.50 M(-13.6%)
$296.10 M(+2.2%)
Mar 2011
-
$85.10 M(+20.5%)
$289.70 M(+7.1%)
Dec 2010
$270.60 M(-11.9%)
$70.60 M(+5.5%)
$270.40 M(+2.9%)
Sep 2010
-
$66.90 M(-0.3%)
$262.70 M(-9.7%)
Jun 2010
-
$67.10 M(+2.0%)
$290.90 M(+1.3%)
Mar 2010
-
$65.80 M(+4.6%)
$287.10 M(-6.5%)
Dec 2009
$307.10 M(+79.0%)
$62.90 M(-33.9%)
$307.10 M(+12.7%)
Sep 2009
-
$95.10 M(+50.2%)
$272.40 M(+22.9%)
Jun 2009
-
$63.30 M(-26.2%)
$221.60 M(+4.4%)
Mar 2009
-
$85.80 M(+204.3%)
$212.30 M(+30.0%)
Dec 2008
$171.60 M(-0.6%)
$28.20 M(-36.3%)
$163.30 M(-9.5%)
Sep 2008
-
$44.30 M(-18.0%)
$180.50 M(+4.5%)
Jun 2008
-
$54.00 M(+46.7%)
$172.80 M(+4.2%)
Mar 2008
-
$36.80 M(-18.9%)
$165.90 M(-4.5%)
Dec 2007
$172.60 M(-0.3%)
$45.40 M(+24.0%)
$173.70 M(+1.3%)
Sep 2007
-
$36.60 M(-22.3%)
$171.40 M(-2.1%)
Jun 2007
-
$47.10 M(+5.6%)
$175.00 M(+0.8%)
Mar 2007
-
$44.60 M(+3.5%)
$173.60 M(-11.0%)
Dec 2006
$173.20 M(-1.2%)
$43.10 M(+7.2%)
$195.00 M(-1.9%)
Sep 2006
-
$40.20 M(-12.0%)
$198.80 M(+0.1%)
Jun 2006
-
$45.70 M(-30.8%)
$198.70 M(-0.2%)
Mar 2006
-
$66.00 M(+40.7%)
$199.00 M(+13.3%)
Dec 2005
$175.30 M(+13.5%)
$46.90 M(+17.0%)
$175.60 M(+4.2%)
Sep 2005
-
$40.10 M(-12.8%)
$168.50 M(+2.9%)
Jun 2005
-
$46.00 M(+8.0%)
$163.70 M(+3.5%)
Mar 2005
-
$42.60 M(+7.0%)
$158.20 M(+13.8%)
Dec 2004
$154.40 M(+11.6%)
$39.80 M(+12.7%)
$139.00 M(+0.5%)
Sep 2004
-
$35.30 M(-12.8%)
$138.30 M(+2.5%)
Jun 2004
-
$40.50 M(+73.1%)
$134.90 M(+7.5%)
Mar 2004
-
$23.40 M(-40.2%)
$125.50 M(-7.1%)
Dec 2003
$138.40 M(+165.6%)
$39.10 M(+22.6%)
$135.10 M(+6.4%)
Sep 2003
-
$31.90 M(+2.6%)
$127.00 M(+134.3%)
Jun 2003
-
$31.10 M(-5.8%)
$54.20 M(0.0%)
Mar 2003
-
$33.00 M(+6.5%)
$54.20 M(+4.0%)
Dec 2002
$52.10 M(+116.2%)
$31.00 M(-175.8%)
$52.10 M(+8.1%)
Sep 2002
-
-$40.90 M(-231.5%)
$48.20 M(-57.1%)
Jun 2002
-
$31.10 M(+0.6%)
$112.40 M(+301.4%)
Mar 2002
-
$30.90 M(+14.0%)
$28.00 M(+16.2%)
Dec 2001
$24.10 M(-74.6%)
$27.10 M(+16.3%)
$24.10 M(-44.0%)
Sep 2001
-
$23.30 M(-143.7%)
$43.00 M(-2.3%)
Jun 2001
-
-$53.30 M(-297.4%)
$44.00 M(-58.2%)
Mar 2001
-
$27.00 M(-41.3%)
$105.30 M(+1.9%)
Dec 2000
$95.00 M(-18.8%)
$46.00 M(+89.3%)
$103.30 M(+80.3%)
Sep 2000
-
$24.30 M(+203.8%)
$57.30 M(+73.6%)
Jun 2000
-
$8.00 M(-68.0%)
$33.00 M(+32.0%)
Mar 2000
-
$25.00 M
$25.00 M
Dec 1999
$117.00 M
-
-

FAQ

  • What is Edwards Lifesciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences annual EBIT year-on-year change?
  • What is Edwards Lifesciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly EBIT year-on-year change?
  • What is Edwards Lifesciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM EBIT year-on-year change?

What is Edwards Lifesciences annual earnings before interest & taxes?

The current annual EBIT of EW is $1.62 B

What is the all time high annual EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high annual earnings before interest & taxes is $1.79 B

What is Edwards Lifesciences annual EBIT year-on-year change?

Over the past year, EW annual earnings before interest & taxes has changed by -$170.90 M (-9.57%)

What is Edwards Lifesciences quarterly earnings before interest & taxes?

The current quarterly EBIT of EW is $394.30 M

What is the all time high quarterly EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly earnings before interest & taxes is $818.90 M

What is Edwards Lifesciences quarterly EBIT year-on-year change?

Over the past year, EW quarterly earnings before interest & taxes has changed by -$26.30 M (-6.25%)

What is Edwards Lifesciences TTM earnings before interest & taxes?

The current TTM EBIT of EW is $1.52 B

What is the all time high TTM EBIT for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM earnings before interest & taxes is $1.84 B

What is Edwards Lifesciences TTM EBIT year-on-year change?

Over the past year, EW TTM earnings before interest & taxes has changed by -$158.80 M (-9.44%)